Pharmacology

Action Mechanism of Action Reference
AGONIST Insulin receptor agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myocardial Infarction 3 D009203 ClinicalTrials
Prediabetic State 3 D011236 ClinicalTrials
Hyperglycemia 3 D006943 ClinicalTrials
Cystic Fibrosis 3 D003550 ClinicalTrials
Hypertension 3 D006973 ClinicalTrials
Atherosclerosis 3 D050197 ClinicalTrials
Hypercholesterolemia 3 D006937 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials
Leukemia 3 D007938 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Diabetic Retinopathy 0 D003930 ClinicalTrials

Related Entries

Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
22.29
Investigations
16.77
General disorders and administration site conditions
14.49
Nervous system disorders
7.74
Skin and subcutaneous tissue disorders
4.38
Vascular disorders
4.38
Musculoskeletal and connective tissue disorders
4.09
Eye disorders
4.08
Psychiatric disorders
3.23
Metabolism and nutrition disorders
2.97
Gastrointestinal disorders
2.73
Cardiac disorders
2.63
Respiratory, thoracic and mediastinal disorders
2.62

Cross References

Resources Reference
CAS NUMBER 160337-95-1
ChEMBL CHEMBL1201497
FDA SRS 2ZM8CX04RZ
Guide to Pharmacology 7572
PubChem 118984454